The multifaceted role of mTOR in cellular stress responses

DNA Repair

Volumn 3, Issue 8-9, 2004, Pages 927-934

  Proud, Christopher G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Amino acids; Apoptosis; DNA damage; Hypoxia; mTOR; Signaling

Indexed keywords

RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

APOPTOSIS; CELL ACTIVITY; CELL CYCLE; CELL ENERGY; CELL GROWTH; CYTOSKELETON; DNA DAMAGE; EUKARYOTE; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RNA STABILITY; RNA TRANSLATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANOXIA; APOPTOSIS; CYTOSKELETON; DNA DAMAGE; HUMANS; MODELS, BIOLOGICAL; MODELS, GENETIC; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; RNA; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EUKARYOTA; MAMMALIA;

EID: 3242892160     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2004.03.012     Document Type: Review

References (65)

1. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15:2001;2177-2196
2. Kim D.H., Sarbassov D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., Tempst P., Sabatini D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 110:2002;163-175
3. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., Tokunaga C., Avruch J., Yonezawa K. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell. 110:2003;177-189
4. Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J.L., Bonenfant D., Oppliger W., Jenoe P., Hall M.N. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell. 10:2003;457-468
5. Kim D.H., Sarbassov D., Ali S.M., Latek R.R., Guntur K.V., Erdjument-Bromage H., Tempst P., Sabatini D. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell. 11:2002;895-904
6. Brunn G.J., Hudson C.C., Sekulic A., Williams J.M., Hosoi H., Houghton P.J., Lawrence J.C., Abraham R.T. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science. 277:1997;99-101
7. Choi K.-M., McMahon L.P., Lawrence J.C. Two motifs in the translational repressor PHAS-I required for efficient phosphorylation by mammalian target of rapamycin and for recognition by raptor. J. Biol. Chem. 278:2003;19667-19673
8. Nojima H., Tokunaga C., Eguchi S., Oshiro N., Hidayat S., Yoshino K., Hara K., Tanaka J., Avruch J., Yonezawa K. The mTOR partner, raptor, binds the mTOR substrates, p70 S6 kinase and 4E-BP1, through their TOS (TOR signaling) motifs. J. Biol. Chem. 278:2003;15461-15464
9. Withers D.J., Ouwens D.M., Nave B.T., van der Zon G.C.M., Alarcon C.M., Cardenas M.E., Heitman J., Maassen J.A., Shepherd P.R. Expression, enzyme activity and subcellular localisation of mammalian target of rapamycin in insulin-responsive cells. Biochem. Biophys. Res. Commun. 241:1998;704-709
10. Desai B.N., Myers B.R., Schreiber S.L. FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc. Natl. Acad. Sci. U.S.A. 99:2002;4319-4324
11. Zhang X., Shu L., Hosoi H., Murti K.G., Houghton P.J. Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture. J. Biol. Chem. 277:2002;28127-28134
12. McMahon L.P., Choi K.-M., Lin T.A., Abraham R.T., Lawrence J.C. The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin. Mol. Cell Biol. 22:2002;7428-7438
13. Beugnet A., Wang X., Proud C.G. The TOR-signaling and RAIP motifs play distinct roles in the mTOR-dependent phosphorylation of initiation factor 4E-binding protein 1 in vivo. J. Biol. Chem. 278:2003;40717-40722
14. O. Meyuhas, E. Hornstein, Translational control of TOP mRNAs, in: N. Sonenberg, J.W.B. Hershey, M.B. Mathews (Eds.), Translational control of gene expression, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2000, pp. 671-693.
15. Pende M., Um S.H., Mieulet V., Sticker M., Goss V.L., Mestan J., Mueller M., Fumagalli S., Kozma S.C., Thomas G. S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol. Cell Biol. 24:2004;3112-3124
16. Tang H., Hornstein E., Stolovich M., Levy G., Livingstone M., Templeton D., Avruch J., Meyuhas O. Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol. Cell Biol. 21:2001;8671-8683
17. Montagne J., Stewart M.J., Stocker H., Hafen E., Kozma S.C., Thomas G. Drosophila S6 kinase: a regulator of cell size. Science. 285:1999;2126-2129
18. Shima H., Pende M., Chen Y., Fumagalli S., Thomas G., Kozma S.C. Disruption of the p70S6k/p85S6k gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17:1998;6649-6659
19. Lawrence J.C., Abraham R.T. PHAS/4E-BPs as regulators of mRNA translation and cell proliferation. Trends Biochem. Sci. 22:1997;345-349
20. Gingras A.-C., Raught B., Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15:2001;807-826
21. Dostie J., Ferraiuolo M., Pause A., Adam S.A., Sonenberg N. A novel shuttling protein, 4E-T, mediates the nuclear import of the mRNA 5′ cap-binding protein, eIF4E. EMBO J. 19:2000;3142-3156
22. Lazaris-Karatzas A., Montine K.S., Sonenberg N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature. 345:1990;544-547
23. De Benedetti A., Rhoads R.E. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc. Natl. Acad. Sci. U.S.A. 87:1990;8212-8216
24. Rousseau D., Gingras A.-C., Pause A., Sonenberg N. The eIF4E-binding protein-1 and protein-2 are negative regulators of cell growth. Oncogene. 13:1996;2415-2420
25. Houghton P.J., Huang S. mTOR as a target for cancer therapy. Curr. Topics Microbiol. Immunol. 279:2004;339-359
26. Mita M.M., Mita A., Rowinsky E.K. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer. Cancer Biol. Ther. 2:2003;S169-S177
27. Rousseau D., Kaspar R., Rosenwald I., Gehrke L., Sonenberg N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 messenger-RNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1065-1070
28. Smith M.R., Jaramillo M., Liu Y.L., Dever T.E., Merrick W.C., Kung H.F. Translation initiation factors induce DNA synthesis and transform NIH 3T3 cells. New Biol. 2:1990;648-654
29. Tan A., Bitterman P., Sonenberg N., Peterson M., Polunovsky V. Inhibition of Myc-dependent apoptosis by eukaryotic translation initiation factor 4E requires cyclin D1. Oncogene. 19:2000;1437-1447
30. Herbert T.P., Fahraeus R., Prescott A., Lane D.P., Proud C.G. Rapid induction of apoptosis mediated through peptides that bind initiation factor eIF4E. Curr. Biol. 10:2000;793-796
31. Browne G.J., Proud C.G. Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269:2002;5360-5368
32. T.E. Harris, J.C. Lawrence, TOR signaling, Science STKE, (2003) (212) re:15.
33. Peng T., Golub T.R., Sabatini D.M. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol. Cell Biol. 21:2002;5575-5584
34. Grolleau A., Bowman J., Pradet-Ballade B., Puravs E., Hanash S., Garcia-Sanz J.A., Beretta L. Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics. J. Biol. Chem. 277:2002;22175-22184
35. McManus E.J., Alessi D.R. TSC1-TSC2: a complex tale of PKB-mediated S6K regulation. Nat. Cell Biol. 4:2002;E214-E216
36. Saucedo L.J., Gao X., Chiarelli D.A., Li L., Pan D., Edgar B.A. Rheb promotes cell growth as a component of the insulin/mTOR signalling network. Nat. Cell Biol. 5:2003;566-571
37. Manning B.D., Cantley L.C. Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28:2003;573-576
38. Proud C.G. Regulation of mammalian translation factors by nutrients. Eur. J. Biochem. 269:2002;5338-5349
39. Hara K., Yonezawa K., Weng Q.-P., Kozlowski M.T., Belham C., Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF4E BP1 through a common effector mechanism. J. Biol. Chem. 273:1998;14484-14494
40. Christie G.R., Hajduch E., Hundal H.S., Proud C.G., Taylor P.M. Intracellular sensing of amino acids in Xenopus laevis oocytes stimulates p70 S6 kinase in a TOR-dependent manner. J. Biol. Chem. 277:2002;9952-9957
41. A. Beugnet, A.R. Tee, P.M. Taylor, C.G. Proud, Evidence that intracellular amino acids regulate translation factor function in mammalian cells, 2002, in preparation.
42. Dennis P.B., Jaeschke A., Saitoh M., Fowler B., Kozma S.C., Thomas G. Mammalian TOR: a homeostatic ATP sensor. Science. 294:2001;1102-1105
43. D.R. Bolster, S.J. Crozier, S.R. Kimball, L.S. Jefferson, AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through downregulated mTOR signaling, J. Biol. Chem. 277, 2002.
44. Krause U., Bertrand L., Hue L. Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes. Eur. J. Biochem. 269:2002;3751-3759
45. Kimura N., Tokunaga C., Dalal S., Richardson C., Yoshino K., Hara K., Kemp B.E., Witters L.A., Mimura O., Yonezawa K. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin 9mTOR signalling pathway. Genes Cells. 8:2003;65-79
46. Inoki K., Zhu T., Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 115:2003;577-590
47. S. Horman, G.J. Browne, U. Krause, J.V. Patel, D. Vertommen, L. Bertrand, A. Lavoinne, L. Hue, C.G. Proud, M.H. Rider, Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis, submitted for publication, 2002.
48. McLeod L.E., Proud C.G. ATP depletion increases phosphorylation of elongation factor eEF2 in adult cardiomyocytes independently of inhibition of mTOR signalling. FEBS Lett. 531:2002;448-452
49. Arsham A.M., Howell J.J., Simon M.C. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J. Biol. Chem. 278:2003;29655-29660
50. Humar R., Kiefer F.N., Berns H., Resink T.J., Battegay E.J. Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J. 16:2002;771-780
51. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W. Modulation of hypoxia-inducible factor 1a expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 59:1999;5830-5835
52. Hudson C.C., Liu M., Otterness D.M., Loomis D.C., Kaper F., Giaccia A.J., Abraham R.T. Regulation of hypoxia-inducible factor 1a expression and function by the mammalian target of rapamycin. Mol. Cell Biol. 22:2002;7004-7014
53. +/- mice. Proc. Natl. Acad. Sci. U.S.A. 98:2001;10320-10325
54. Neshat M.S., Mellinghoff I.K., Tran C., Stiles B., Thomas G., Petersen R., Frost P., Gibbons J.J., Wu H., Sawyers C.L. Enhanced sensitivity of PTEN-deficient tumours to inhibition of FRAP/mTOR. Proc. Natl. Acad. Sci. U.S.A. 98:2001;10314-10319
55. Tee A.R., Proud C.G. DNA damage causes inactivation of translational regulators linked to mTOR signalling. Oncogene. 19:2000;3021-3031
56. Coldwell M.J., Mitchell S.A., Stoneley M., MacFarlane M., Willis A.E. Initiation of APAF-1 translation by internal ribosome entry. Oncogene. 19:2000;899-905
57. Horton L.E., Bushell M., Barth-Baus D., Tilleray V.J., Clemens M.J., Hensold J.O. p53 activation results in rapid dephosphorylation of the eIF4E-binding protein 4E-BP1, inhibition of ribosomal protein S6 kinase and inhibition of translation initiation. Oncogene. 21:2002;5325-5334
58. Cairns C.A., White R.J. p53 is a general repressor of RNA polymerase III transcription. EMBO J. 17:2003;3112-3123
59. Kumar V., Sabatini D., Pandey P., Gingras A.-C., Majumder P.K., Kumar M., Yuan Z.-M., Carmichael G., Weichselbaum R., Sonenberg N., Kufe D., Kharbanda S. Regulation of the rapamycin and FKBP-target 1/mammalian target of rapamycin and cap-dependent initiation of translation by the c-Abl protein-tyrosine kinase. J. Biol. Chem. 275:2000;10779-10787
60. Metcalfe S.M., Canman C.E., Milner J., Morris R.E., Goldman S., Kastan M.B. Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells. Oncogene. 15:1997;1635-1642
61. Yang D.-Q., Kastan M.B. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat. Cell Biol. 2:2000;893-898
62. Wang X., Li W., Parra J.-L., Beugnet A., Proud C.G. The C-terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylation. Mol. Cell Biol. 23:2003;1546-1557
63. Zhang Y., Dong Z., Nomura M., Zhong S., Chen N., Bode A.M. Signal transduction pathways involved in phosphorylation and activation of p70S6K following exposure to UVA radiation. J. Biol. Chem. 276:2001;20913-20923
64. Brenneisen P., Wenk J., Wlaschek M., Krieg T., Scharffetter-Kochanek K. Activation of p70 ribosomal protein S6 kinase is an essential step in the DNA damage-dependent signaling pathway responsible for the ultraviolet B-mediated increase in interstitial collagenase (MMP-1) and stromelysin-1 (MMP-3) protein levels in human dermal fibroblasts. J. Biol. Chem. 275:2000;4336-4344
65. Huang S., Liu L.N., Hosoi H., Dilling M.B., Shikata T., Houghton P.J. p53/p21CIP1 cooperate in enforcing rapamycin-induced G1 arrest and determine the cellular response to rapamycin. Cancer Res. 61:2001;3373-3381